Protein Kinase Targets

Protein kinases play a critical role in signaling pathways that control fundamental cellular processes. To date, more than 500 human protein kinase genes have been identified. These offer a multitude of potential kinase targets and an exciting opportunity for the pharmaceutical industry for therapeutic intervention, especially in the area of cancer, immune diseases and diabetes. New developments in inhibiting the catalytic function of kinases, as well as promising technologies in the proteomic field expand the possibilities of the rapidly growing field of kinases in drug development.

Join the team of top experts and discuss hot topics such as:

• Enabling Structure-Based Drug Design
• Furthering Target Identification
• Developing Selective Inhibitors of Various Kinase Targets
• Utilization of Kinase Structures and Inhibitors to Enable Increasingly Selective Drug Targeting
• New Insights into Conformational Variability Between Kinases
• Functional Analysis
• Kinase Profiling

M. Velleca, CGI Pharmaceuticals
S. Tan, Eli Lilly
U. Boemer, Schering
F. Piu, Acadia Pharmaceuticals
M. Azam, Harvard Medical School
A. Joly, Exelixis
Y. Dai, Abbott
M. Lobell, Bayer Healthcare
C. McInnes, Cyclacel